The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

FARN FARON PHARMACEUTICALS OY ORD NPV (DI)




 Page 1 of 3

| 1 | 2 | 3 | Next

Time/Date Code Headline Source Impact
07:00 26-Jun-2019 FARN Phase II INFORAAA study update RNS -
07:00 14-Jun-2019 FARN Final results from YODA study RNS +17.98% Up
12:27 28-May-2019 FARN Results of AGM RNS +13.90% Up
09:32 24-May-2019 FARN AGM update, Board & management changes RNS +23.15% Up
12:51 22-May-2019 FARN Grant of Options RNS +30.57% Up
09:21 21-May-2019 FARN Holding(s) in Company RNS +25.66% Up
09:16 16-May-2019 FARN Holding(s) in Company RNS +14.35% Up
07:01 14-May-2019 FARN Holdings in Company RNS +10.42% Up
07:00 14-May-2019 FARN Share Subscription and Issue of Equity RNS +10.42% Up
07:05 07-May-2019 FARN Notice of AGM RNS +0.88% Up
07:00 07-May-2019 FARN Final Results for the year ended 31 December 2018 RNS +0.88% Up
17:20 02-May-2019 FARN Statement regarding Price Movement RNS +21.63% Up
14:05 02-May-2019 FARN Second Price Monitoring Extn RNS +21.63% Up
14:00 02-May-2019 FARN Price Monitoring Extension RNS +21.63% Up
07:00 29-Apr-2019 FARN Results from the Japanese Phase III study RNS +12.41% Up
16:09 25-Apr-2019 FARN Holding(s) in Company RNS -0.61% Down
13:20 12-Apr-2019 FARN Holding(s) in Company RNS +0.93% Up
07:00 11-Apr-2019 FARN First expansion cohort for MATINS trial part 2 RNS +1.43% Up
11:41 10-Apr-2019 FARN Holding(s) in Company RNS +0.43% Up
07:00 05-Apr-2019 FARN Notice of Results RNS -0.49% Down

 Page 1 of 3

| 1 | 2 | 3 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Company Information
Company website http://www.faron.com
Company address Joukahaisenkatu 6, Turku, FIN-20520, Finland
FTSE ICB sector Pharmaceuticals & Biotechnology
FTSE ICB subsector Biotechnology
Company market cap, £m* 50.08
Admission date 17 Nov 2015
*The company market capitalization reflects the London listed element of Ordinary and Preference shares only and is approximate. Data provided by FTSE Russell.

Security Information
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
Market AIM
Market identifier code (MIC) AIMX
Trading service SETSqx
Trading segment ASQ1
Listing category -
Country of share register GB
ISIN FI4000153309
SEDOL BYMKYR0
Exchange market size 5,000
Security market cap, £m 50.08
*The market capitalisation of the security reflects data from previous trading day.


FARON PHARMA share news analysis (FARN)